Recent news on Fluocinolone Acetonide

Medicis Begins Shipping PERLANE to Physicians  -  May 21, 2007
Primenewswire (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel,

Medidur Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment  -  Apr 24, 2007
eMaxHealth.com,Medidur, a tiny, injectable intravitreal insert, is being studied as a way to deliver a very low dose of fluocinolone acetonide, a corticosteroid,to the

Alimera Sciences' Medidur Trial Exceeds 500 Patient Mark in Phase ...  -  Apr 23, 2007
PharmaLive.com (press release),Medidur, a tiny, injectable intravitreal insert, is being studied as a way to deliver a very low dose of fluocinolone acetonide, a corticosteroid,

pSivida Signs $165 Million(US) Collaborative Research and ...  -  Apr 5, 2007
Nanotechwire.com,Medidur in combination with Fluocinolone Acetonide is in Phase III clinical trials in DME in collaboration with Alimera Sciences Inc.,

Pfizer spies pSivida's injectable eye treatment  -  Apr 4, 2007
DrugResearcher.com,The insert is being studied as a way of delivering fluocinolone acetonide (a corticosteroid) to treat diabetic macular edema (DME), and has been designed to

Medicis Declares Cash Dividend  -  Mar 14, 2007
Primenewswire (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel,

PSDV: Retisert(TM) Receives Product Bill Code for Medicare ...  -  Jan 29, 2007
Insurance News Net,RetisertTM is surgically placed into the back of the eye and releases the steroid, fluocinolone acetonide at a constant rate over a period of up to 30

pSivida announces A$11.5m (US$9m) placement  -  Feb 19, 2007
dBusinessNews Boston (press release),...failure of Medidurâ„¢ to release fluocinolone acetonide at the same rate as Retisertâ„¢; our inability to recruit patients for the Phase III Medidurâ„¢ for

Mergers, Acquisitions, etc.  -  Feb 16, 2007
OSN SuperSite (subscription),...which will finance the development of pSivida’s Medidur (fluocinolone acetonide) drug delivery system for treating diabetic macular edema, according to

Medicis to Present At Roth Capital Partners 19th Annual OC Conference  -  Feb 15, 2007
PharmaLive.com (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel,

AGI Dermatics Presents Comparative Data of 4% Hydroquinone ...  -  Feb 5, 2007
PR Newswire (press release),...and patches treated with an equal amount of a cream containing 4% HQ, 0.01% fluocinolone acetonide, (a steroid) and 0.05% tretinoin, a retin-a (HA/F+T).

pSivida Completes US$2.9m Placement  -  Dec 20, 2006
Genetic Engineering News (press release),Medidur(TM) for the delivery of a steroid (fluocinolone acetonide) for the treatment of the chronic eye disease diabetic macular edema (DME).

Medicis to Present At JPMorgan 25th Annual Healthcare Conference  -  Jan 4, 2007
PharmaLive.com (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel,

pSivida Enters Licensing Negotiations with Major Global Pharma for ...  -  Dec 27, 2006
dBusinessNews Boston (press release),...failure of Medidurâ„¢ to release fluocinolone acetonide at the same rate as Retisertâ„¢; our inability to recruit patients for the Phase III Medidurâ„¢ for

pSivida Enters Licensing Negotiations with Major Global Pharma for ...  -  Dec 26, 2006
PharmaLive.com (press release),...diabetic retinopathy severity score as Retisert(TM) for DME; failure of Medidur(TM) to release fluocinolone acetonide at the same rate as Retisert(TM);

Alimera Sciences and Bausch & Lomb Announce Transaction for Alaway ...  -  Dec 20, 2006
dBusinessNews Atlanta (press release),2005 to study diabetic macular edema (DME) patients treated using Medidur™ with fluocinolone acetonide, the company’s pharmacologic treatment for DME.

pSivida Enters Licensing Negotiations with Major Global Pharma for ...  -  26 Dec 2006
Business Wire (press release),...improvement in visual acuity and diabetic retinopathy severity score as Retisertâ„¢ for DME; failure of Medidurâ„¢ to release fluocinolone acetonide at the ...

pSivida raises $3.7m, re-appoints Aston to board  -  Dec 19, 2006
WA Business News,...fund pSivida's portion of costs to develop its lead ophthalmic development product, MedidurTM for the delivery of a steroid (fluocinolone acetonide) for the ...

Alimera Sciences and Bausch & Lomb Announce Transaction for Alaway ...  -  Dec 20, 2006
dBusinessNews Atlanta (press release),...a Phase III clinical trial in October 2005 to study diabetic macular edema (DME) patients treated using Medidur™ with fluocinolone acetonide, the company’s ...

Medicis Declares Cash Dividend  -  Dec 14, 2006
Primenewswire (press release),Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), ZIANA(TM ...

Alimera Sciences Completes Second Tranche of Series B Financing ...  -  Nov 27, 2006
Yahoo! News (press release)2005 initiated a Phase III clinical trial to study diabetic macular edema (DME) patients treated using Medidur(TM) with fluocinolone acetonide, the company's ...

Medicis and Dow Pharmaceutical Sciences Announce FDA Approval of ...  Nov 7, 2006
Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA ... -PrimeZone (press release), Medicis Announces Third Quarter 2006 Conference Call and Webcast  Nov 6, 2006
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... -PrimeZone (press release), First Patient Implanted in pSivida European Pancreatic Cancer ...  Oct 9, 2006
...improvement in visual acuity and diabetic retinopathy severity score as Retisertâ„¢ for DME; failure of Medidurâ„¢ to release fluocinolone acetonide at the ... -Business Wire (press release), Misunderstood and Often Untreated: Melasma, or ‘Pano,’ Affects ...  Oct 17, 2006
...prompt discontinuation of therapy. Tri-Luma(R) Cream contains the corticosteroid fluocinolone acetonide. Systematic absorption of ... -Hispanic PR Wire (press release), First Patient Implanted in pSivida European Pancreatic Cancer ...  Oct 9, 2006
...improvement in visual acuity and diabetic retinopathy severity score as Retisert(TM) for DME; failure of Medidur(TM) to release fluocinolone acetonide at the ... -Genetic Engineering News (press release), Medicis to Present at UBS Global Life Sciences Conference  Sep 22, 2006
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... -PrimeZone

pSivida: Retisert(TM) Wins International Award  Sep 13, 2006
...'Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis' published in Ophthalmology 2005 and co-authored ... -Business Wire

Initiation of Phase II Clinical Study of Novel Ophthalmic Product  Sep 19, 2006
...improvement in visual acuity and diabetic retinopathy severity score as Retisert(TM) for DME; failure of Medidur(TM) to release fluocinolone acetonide at the ... -PharmaLive.com

Alimera Sciences Receives FDA Approval To Market Alaway(TM) OTC ...  -  Dec 6, 2006
Medical News Today (press release),2005 initiated a Phase III clinical trial to study diabetic macular edema (DME) patients treated using Medidur(TM) with fluocinolone acetonide, the company's ...

pSivida and Nordic Biotech Sign MOU for A$33.7M (US$26M) for ...  -  Nov 13, 2006
PharmaLive.com (press release),...procedure. Medidur(TM)and Retisert can deliver the same steroid (fluocinolone acetonide or FA), at a similar rate to the back of the eye. ...

Medicis to Present at Credit Suisse Healthcare Conference  -  Nov 13, 2006
PharmaLive.com (press release),Tablets, TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), ZIANA(TM ...

pSivida Announces Transdermal Drug Delivery Program  -  Nov 20, 2006
PharmaLive.com (press release),...improvement in visual acuity and diabetic retinopathy severity score as Retisert(TM) for DME; failure of Medidur(TM) to release fluocinolone acetonide at the ...

pSivida Announces Transdermal Drug Delivery Program  -  Nov 20, 2006
Business Wire (press release),...improvement in visual acuity and diabetic retinopathy severity score as Retisertâ„¢ for DME; failure of Medidurâ„¢ to release fluocinolone acetonide at the ...

pSivida and Nordic Biotech Sign MOU for A$33.7M (US$26M) for ...  -  Nov 13, 2006
Nanotechnology.net (press release),...procedure. Medidurâ„¢ and Retisert can deliver the same steroid (fluocinolone acetonide or FA), at a similar rate to the back of the eye. ...

Non-Exec Director Resigns from pSivida Board  Aug 28, 2006
...improvement in visual acuity and diabetic retinopathy severity score as Retisert(TM) for DME; failure of Medidur(TM) to release fluocinolone acetonide at the ... -Genetic Engineering News

Medicis Announces Second Quarter 2006 Conference Call and Webcast  Jul 31, 2006
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... -PrimeZone

Medical Edge: Many remedies for common skin disorder  Jul 15, 2006
New medications you might not have tried include fluocinolone acetonide (Capex), an anti-inflammatory corticosteroid shampoo, and dermasmoothe (Dermasmoothe F/S ... -Bryan College Station Eagle

Health care tips for moms-to-be  Jul 10, 2006
...is an available topical treatment for melasma: a stable drug with a fixed combination of three active ingredients namely Fluocinolone acetonide 0.01 percent ... -Manila Standard Today

Medicis Names Jason Hanson Executive Vice President and General ...  Jul 12, 2006
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... -PrimeZone

pSivida to Present at The NanoEquity Europe 2006 Conference  Jul 10, 2006
...improvement in visual acuity and diabetic retinopathy severity score as Retisert(TM) for DME; failure of Medidur(TM) to release fluocinolone acetonide at the ... -Genetic Engineering News

Euronext Paris) - Ipsen : Medicis and Ipsen decide to focus ...  Jul 12, 2006
...benzoyl peroxide), LIDEX® (fluocinonide) Cream, 0.05%, VANOS™ (fluocinonide) Cream, 0.1%, and SYNALAR® (fluocinolone acetonide), BUPHENYL® (sodium ... -Euronext (persbericht)

pSivida to Present at the Sachs Associates: London Biotech ...  Jun 22, 2006
...improvement in visualacuity and diabetic retinopathy severity score as Retisert(TM) forDME; failure of Medidur(TM) to release fluocinolone acetonide at thesame ... -Finanzen.net



PSIVIDA QUARTERLY CASHFLOW - MARCH 2006 COMMENTARY AND HIGHLIGHTS  May 1, 2006
...results of Bausch & Lomb's two randomized trials to evaluate the safety and efficacy of the Retisert(TM) implant in releasing fluocinolone acetonide in the ... - Small Times

pSivida to raise $29m to fund clinical trials  May 2, 2006
...of Uveitis, a sight threatening disease that affects approximately 175,000 patients in the US RetisertTM releases the drug fluocinolone acetonide (FA) with a ... - WA Business News

Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP ...  May 8, 2006
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... - PharmaLive.com

æ?¥æº?：生命ç»?纬  Apr 16, 2006
Medidur is a tiny, injectable device designed for the sustained release of the drug fluocinolone acetonide and is being studied for the treatment of Diabetic ... - BioX





pSivida News: Retisert(TM) Slows Progression of Diabetic ...  Apr 3, 2006
...results of Bausch & Lomb's two randomized trials to evaluate the safety and efficacy of the Retisert(TM) implant in releasing fluocinolone acetonide in the ... - Genetic Engineering News

pSivida Release: Positive European trial results for Retisert(TM)  Apr 6, 2006
Retisert(TM) is surgically implanted into the eye and is approved to release a constant amount of the drug, fluocinolone acetonide, over a treatment period of ... - Genetic Engineering News

(PZ) Medicis to Ring the Opening Bell of the NYSE  Mar 20, 2006
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... - Houston Chronicle

pSivida Announces Medidur Manufacture Certified to be GMP ...  Mar 20, 2006
Medidur is a tiny, injectable device designed for the sustained release of the drug fluocinolone acetonide and is being studied for the treatment of Diabetic ... - Nanotechwire.com

Safety board recommends continuation of Alimera/pSivida trial  Mar 21, 2006
Medidur is a tiny, injectable device being studied as a way to deliver fluocinolone acetonide, a corticosteroid, to the retina for up to three years as a ... - Pharmaceutical Business Review

pSivida Announces Medidur(TM) Manufacture Certified to be GMP ...  Mar 20, 2006
Medidur(TM) is a tiny, injectable device designed for the sustained release of the drug fluocinolone acetonide and is being studied for the treatment of ... - Business Wire

pSivida Announces Medidur(TM) Manufacture Certified to be GMP ...  Mar 20, 2006
Medidur(TM) is a tiny, injectable device designed for thesustained release of the drug fluocinolone acetonide and is beingstudied for the treatment of Diabetic ... - Finanzen.net

Uveitis Long Term Trial Results Positive for pSivida; Second Set ...  Feb 21, 2006
Retisert(TM) is surgically implanted into the eye and is approved to release a constant amount of the drug, fluocinolone acetonide, over a treatment period of ... - Genetic Engineering News,

Diabetic Macular Edema trial with Retisert; Positive Results for ...  Feb 22, 2006
DR. Retisert for DME is surgically implanted into the eye and releases a constant amount of the drug, fluocinolone acetonide. Retisert ... - Nanotechwire.com,

Bausch & Lomb Teams with Novartis Ophthalmics To Co-Promote Bausch ...  09 Feb 2006
...(NYSE: NVS), will co-promote Bausch & Lomb's patented orphan drug Retisert(TM) (fluocinolone acetonide intravitreal implant) 0.59 mg, in the United States. ... - Genetic Engineering News

Medicis to Present at Merrill Lynch 17th Annual Global ...  Feb 3, 2006
TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, and SYNALAR(R) (fluocinolone acetonide), BUPHENYL(R ... - Genetic Engineering News

Alimera Sciences Names Proven Atlanta Executive Eiswirth New CFO  Jan 25, 2006
2005 initiated a Phase III clinical trial to study diabetic macular edema (DME) patients treated using Medidur(TM) with fluocinolone acetonide, the company's ... - Canada NewsWire

Mississippi’s First Procedure with Retisertâ„¢ May Help Save Eye ...  Jan 19, 2006
...& Lomb's Retisert â„¢, a tiny drug reservoir designed to deliver sustained level levels of the well-known corticosteroid fluocinolone acetonide directly to the ... - Emediawire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional